Document:

entest_ex10-1.htm

Exhibit 10.1

 

 

February 17, 2011

Asaf A. Qadeer, DVM, MPVM

Riverdale Animal Hospital

128 E. Riverdale Ave

Orange, CA 92865

Re:           Non-Binding Letter of Intent

Dear Dr. Qadeer:

This Letter of Intent (“LOI”) constitutes a proposal from Entest BioMedical, Inc. (hereinafter, “Buyer”) to Riverdale Animal Hospital (“RAH”) located at 128 E. Riverdale Ave., Orange, CA 92865 (the “Property #1”), Charlinda Animal Hospital (“CAH”) located at 25222 Charlinda Dr., Suite C, Mission Viejo, CA 92691 (the “Property #2”), Culver Pet Clinic (“CPC”) located at 14130 Culver Dr., Suite B, Irvine, CA 92604 (the “Property #3”) and Asaf A. Qadeer, DVM, MPVM (“Seller”) to buy 100% of the assets utilized in the  Properties (“Business Assets”) owned by Seller in connection with the operation and management of its business (the “Business”). Buyer and Seller may be referred to individually as “Party” and collectively as “Parties”. Property #1, Property #2 and Property #3 may be referred to collectively as the “Properties”. The contemplated transaction shall be referred to as “the Transaction” and does not pertain to any real estate the Seller owns.  Any real estate transaction(s) related to these Properties will be covered under a separate agreement.

This proposal supersedes any other previous written or oral proposals or communications between the Parties. The terms of this proposal shall be as follows:

	
  

	
1.

	
Purchase Price.

 

The Purchase Price for the acquisition of 100% of the Business Assets shall be seven hundred thousand dollars ($700,000.00) to be paid as follows.

 

	
  

	
a.

	
Buyer shall pay $700,000 in a combination of cash, assumption of debt and issuance of Entest BioMedical Inc.’s common stock (OTCBB: ENTB), hereafter referred to as the “Purchase Price Components”.  The percentages of each of these components will be determined once the due diligence has been completed by Buyer.

 

	
  

	
b.

	
Buyer shall deposit as collateral for the completion of the Transaction a total of 200,000 common shares of ENTB stock (“Escrow Deposit”) with Herman H. Pettegrove (“Escrow Agent”), Attorney at Law, 1350 Main Street, Venice, CA 90291 – 310.392.5400 within two (2) days of execution by the parties of This LOI (as of February 17, 2011, ENTB closed trading at $3.84 per share, valuing the Escrow Deposit at $768,000 as of that date). The terms of the Escrow shall provide that:

 

	
  

	
i.

	
In the event that Definitive Purchase Agreement (“DPA” as defined in Section 2) is not executed by the Parties on or before April 30, 2011 then the Escrow Deposit shall be returned to Buyer;

 

	
  

	
ii.

	
In the event that negotiations regarding the Transaction terminate due to (a) a breach of 3(m) or 3(n) by the Seller then the Escrow Deposit shall be returned to Buyer and;

 

	
  

	
iii.

	
It is agreed by the Parties that Escrow Agent shall serve as such regarding any escrow which is required to be established in accordance with any DPA entered into by and among the Parties.

 

	
  

	
c.

	
On the Date of Closing of Sale the sum of the Purchase Price Components totaling $700,000 shall be paid to Seller and;

 

	
  

	
d.

	
Any debt assumed will reduce the other Purchase Price Components by the amount assumed.

 

 

  

1

  

	
  

	
2.

	
Due Diligence

 

Upon the deposit of the Escrow Deposit by Buyer and for a period of thirty (30) days thereafter (the “Due Diligence Period”), Seller shall provide Buyer with reasonable access to all of the Business’s books, records, legal documents, assets and other information (the “Books and Records”), all as no cost to Buyer. At such time as Due Diligence Period has expired the Parties shall use their best efforts to negotiate and execute a Definitive Purchase Agreement (“DPA”) whereby Seller shall sell 100% of the assets of the Businesses to Buyer under terms and conditions similar to those set forth herein. The Parties agree and acknowledge that this list of terms and conditions set forth herein is not intended to be all inclusive and the DPA to be executed by the Parties may contain terms different or in addition to those set forth herein. Both Parties shall use their best efforts to execute a DPA no later than April 1, 2011 with the Transaction closing no later than April 15, 2011 (the “Closing Date of Sale”).

 

	
  

	
3.

	
Basic Terms.

 

The DPA shall include terms and conditions similar to the following:

 

	
  

	
a.

	
Upon the mutual execution by the Parties of the Definitive Purchase Agreement, Buyer shall have no contingencies and his obligation to close the Transaction shall be unconditional;

 

	
  

	
b.

	
Seller shall assign the assets to Buyer;

 

	
  

	
c.

	
Seller shall retain cash and accounts receivable from Business and Buyer shall have no interest or obligations with respect thereto to the extent such retention shall not result in the Business having liabilities in excess of what may be agreed upon by the Parties pursuant to a DPA as of the Closing Date of Sale;

 

	
  

	
d.

	
Buyer shall indemnify and protect Seller from all liabilities or obligations of the Business  after the Closing Date of Sale;

 

	
  

	
e.

	
Seller shall indemnify and protect Buyer from all liabilities or obligations of the Business  prior to the closing Date of Sale;

 

	
  

	
f.

	
Seller shall not, within a radius of ten (10) miles of any of the Properties, directly or indirectly engage in the practice of veterinary, other than as provided in the agreement, for a period of five (5) years from the Closing Date, unless Seller is employed by Buyer;

 

	
  

	
g.

	
Seller agrees that it shall not directly or indirectly induce any former patients to patronize anyone other than Buyer for a period of five (5) years from the Closing Date;

 

	
  

	
h.

	
Seller agrees that it shall not solicit for hire employees of its Business for a period of five (5) years from the Closing Date;

 

	
  

	
i.

	
Seller and Buyer agree to enter into an employment agreement such that Seller shall be employed by Buyer as follows: (a) Annual salary and number of days to be worked per week to be mutually agreed to by the Buyer and Seller; (b) a cash bonus equal to 5.00% of the annual gross collections over baseline revenue of $900,000.00; a stock bonus equal to 5% of the annual gross collections over baseline revenue of $900,000.00.

 

	
  

	
j.

	
Seller shall represent and warrant that all tax returns and financial information delivered to Buyer in connection herewith are true and accurate and that to the best of Seller’s knowledge it is not aware of any actual, contingent or threatened liabilities, lawsuits or claims against it for any act or omission in connection with the Businesses or operation of the Business;

 

 

  

2

  

	
  

	
k.

	
Buyer shall represent and warrant that it understands that it is purchasing the assets  comprising the Business “as is” without representation or warranty and the Seller is making no representation or warranty with respect to the future success of the Business;

 

	
  

	
l.

	
The Parties shall be responsible for their own costs or attorneys, advisor and accountants in connection with the consummation of the Transaction.

 

	
  

	
m.

	
If any Party fails to negotiate in good faith, or if each Party hereto has not entered into the Definitive Purchase Agreement by April 1, 2011, then any obligation to negotiate and prepare the DPA or otherwise deal with any other Party to this LOI shall immediately terminate.

 

	
  

	
n.

	
Seller agrees that it shall not entertain any offers to purchase the Business Assets or Business during the term of this LOI;

 

	
  

	
o.

	
Each Party shall be solely responsible for its own expenses, legal fees and consulting fees related to the negotiations described in the LOI, whether or not any of the transactions contemplated in the LOI are consummated;

 

	
  

	
p.

	
VENUE, CHOICE OF LAW. The terms and conditions of the LOI shall be governed by and construed in accordance with the laws of the State of California, without reference to its choice of law rules. Any action arising as a result of this Letter shall be brought in the state courts located in San Diego County, State of California.

 

	
  

	
q.

	
Other than the covenants in Sections 1(b), 3(m), 3(n), 3(o) and 3(p) of this LOI, this LOI is not binding upon either the buyer or the Seller, and the Acquisition is subject to the negotiation and execution of a definitive acquisition agreement between the Purchaser, Company and Seller.

 

Very truly yours,

“Buyer”

By: /s/David Koos

Entest BioMedical, Inc.

David Koos, CEO

Date: February 17, 2011

AGREED AND ACCEPTED THIS 17th DAY OF February, 2011:

“Seller”

By: /s/ Asaf A Qadeer

Asaf A. Qadeer, DVM, MPVM on behalf of

Riverdale Animal Hospital, Charlinda Animal Hospital,

Culver Pet Clinic and Asaf A. Qadeer / Seller

  

 

 

  

3Unassociated Document

Exhibit 10.7

Summary of Compensation Arrangements with Directors

2010 Fiscal Year

For the 2010 fiscal year, the independent directors of the Board determined that each of the Company’s directors would receive a cash retainer fee for his service, paid quarterly. The total cash retainer paid to each director was as follows:

	
Director Name

	 	
Cash Retainer during Fiscal Year 2010

	 
	
J. Ward McConnell, Jr.

Executive Chairman of the Board

	 	$	150,000	 
	
Marc H. McConnell

Executive Vice Chairman of the Board

	 	$	58,000	 
	
Thomas E. Buffamante

	 	$	30,000	 
	
David R. Castle

	 	$	30,000	 
	
Fred W. Krahmer

	 	$	30,000	 
	
James Lynch

	 	$	30,000	 
	
Douglas McClellan

	 	$	30,000	 

The Company also reimburses directors for out-of-pocket expenses related to their attendance at board meetings and performance of other services as Board members.

In addition, the independent directors of the Board determined that the Executive Chairman of the Board and Executive Vice Chairman of the Board would be eligible for discretionary cash bonuses following fiscal year end, based on Company performance and services rendered during the fiscal year, and in accordance with a recommendation by independent directors.

Further, pursuant to the Company’s 2007 Non-Employee Directors’ Stock Option Plan, each director is automatically granted non-qualified stock options to purchase 2,000 (post-split) shares of the Company’s common stock on the date of the 2010 Annual Meeting of Stockholders. The options have a five-year term and were immediately exercisable at a price equal to the grant-date fair value.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}]]